At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Dexcom G6 CGMdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Physician-based Decision Support in Patients With Type 1 Diabetes on Multiple Daily Injection Therapy
In Brief
A clinical study evaluating Dexcom G6 CGM for Type 1 Diabetes Mellitus and 3 related conditions. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The goal of this study is to assess the impact of physician-driven insulin setting changes in type 1 patients using multiple daily injection insulin therapy with exercise. This is a short outpatient study with multiple outpatient and home exercise sessions with an assigned type of exercise.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus, MDI, CGM, Exercise
CountriesUnited States
CollaboratorsDexCom, Inc.
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartJul 2018
Primary CompletionMay 2019
TodayJul 2026
First PostedFeb 23, 2018
Enrollment StartJul 18, 2018
Primary CompletionMay 8, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.4 years ago
Interventions
Dexcom G6 CGMdevice
Subjects will wear a Dexcom G6 CGM for the 28 days they are on study.